Study Finds Biofield Therapy Slows Pancreatic Cancer Progression and Reduces Metastasis
Biofield therapy (BT)—a non-invasive, practitioner-administered therapy—can significantly slow the growth and spread of pancreatic cancer in pre-clinical models, according to a new study led by researchers at The University of Texas MD Anderson Cancer Center and funded by Emerald Gate Charitable Trust. The findings, published today in Cancer Medicine, mark one of the most comprehensive investigations to date on the biological effects of BT.
